Introduction: Advanced stage neuroblastoma is associated with 60-70% mortality. We propose that expression microarrays can be used to effectively identify novel biomarkers and targets for high risk disease.Methods: Using a cDNA microarray comparing tumor tissue from high risk versus low risk disease, an expression sequence tag (EST) over-expressed in high risk neuroblastoma was identified and found...
Financed by the National Centre for Research and Development under grant No. SP/I/1/77065/10 by the strategic scientific research and experimental development program:
SYNAT - “Interdisciplinary System for Interactive Scientific and Scientific-Technical Information”.